Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The value of the stock is tied to the eventual cash in their bank account divide

If someone offers to buy-out PTSC it will be because of the patents. In that case, they would also need to buy-out TPL's interest in them. This would probably not be that hard to do if the offer is great enough. If we get a positive Markman ruling I had rather see us not being bought out as the dividends sound very good to me right now. :) GL, ads

Share
New Message
Please login to post a reply